Encompass Health Corporation $EHC Shares Sold by Foster & Motley Inc.

Foster & Motley Inc. reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 7.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,514 shares of the company’s stock after selling 1,125 shares during the period. Foster & Motley Inc.’s holdings in Encompass Health were worth $1,780,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Pinnacle Wealth Planning Services Inc. lifted its stake in shares of Encompass Health by 4.0% during the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock worth $263,000 after buying an additional 99 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares during the period. UMB Bank n.a. lifted its position in Encompass Health by 10.9% during the second quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock valued at $146,000 after purchasing an additional 117 shares during the period. Arlington Trust Co LLC lifted its position in Encompass Health by 22.9% during the first quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares during the period. Finally, Exchange Traded Concepts LLC lifted its position in Encompass Health by 1.9% during the second quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company’s stock valued at $993,000 after purchasing an additional 152 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently issued reports on EHC. Bank of America boosted their target price on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. KeyCorp boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Tuesday, September 16th. Truist Financial boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Finally, UBS Group boosted their target price on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, October 2nd. One equities research analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the stock. According to data from MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average price target of $139.86.

Encompass Health Stock Up 1.3%

EHC opened at $124.55 on Friday. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.86. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company has a fifty day moving average of $123.56 and a two-hundred day moving average of $117.26. The stock has a market capitalization of $12.55 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 2.18 and a beta of 0.93.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a dividend of $0.19 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Wednesday, October 1st. Encompass Health’s dividend payout ratio is presently 14.87%.

Insider Activity at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.